Caixin China Biz Roundup: Beijing Approves Pfizer Covid Drug for Emergency Use

Feb.14.2022

Regulator gives treatment greenlight for vulnerable patients; Chinese firms still keen to go public in the U.S.; and blogger in hot water over negative smartphone reviews

00:00

00:00/00:00

Contact senior podcast producer Nandini Venkata (nandinivenkata@caixin.com)

Download our app to receive breaking news alerts and read the news on the go.

Get our weekly free Must-Read newsletter.

Share this article

Open WeChat and scan the QR code

MORE WAYS TO LISTEN